1. Home
  2. NUVB vs IE Comparison

NUVB vs IE Comparison

Compare NUVB & IE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NUVB
  • IE
  • Stock Information
  • Founded
  • NUVB 2018
  • IE 2020
  • Country
  • NUVB United States
  • IE United States
  • Employees
  • NUVB N/A
  • IE N/A
  • Industry
  • NUVB Biotechnology: Pharmaceutical Preparations
  • IE Metal Mining
  • Sector
  • NUVB Health Care
  • IE Basic Materials
  • Exchange
  • NUVB Nasdaq
  • IE Nasdaq
  • Market Cap
  • NUVB 837.0M
  • IE 1.2B
  • IPO Year
  • NUVB N/A
  • IE 2022
  • Fundamental
  • Price
  • NUVB $3.15
  • IE $8.94
  • Analyst Decision
  • NUVB Strong Buy
  • IE Strong Buy
  • Analyst Count
  • NUVB 6
  • IE 3
  • Target Price
  • NUVB $8.17
  • IE $12.67
  • AVG Volume (30 Days)
  • NUVB 6.6M
  • IE 898.5K
  • Earning Date
  • NUVB 11-05-2025
  • IE 11-07-2025
  • Dividend Yield
  • NUVB N/A
  • IE N/A
  • EPS Growth
  • NUVB N/A
  • IE N/A
  • EPS
  • NUVB N/A
  • IE N/A
  • Revenue
  • NUVB $14,355,000.00
  • IE $3,806,000.00
  • Revenue This Year
  • NUVB $332.80
  • IE $12.72
  • Revenue Next Year
  • NUVB $360.12
  • IE $18.13
  • P/E Ratio
  • NUVB N/A
  • IE N/A
  • Revenue Growth
  • NUVB 900.35
  • IE 35.54
  • 52 Week Low
  • NUVB $1.54
  • IE $4.50
  • 52 Week High
  • NUVB $4.09
  • IE $13.25
  • Technical
  • Relative Strength Index (RSI)
  • NUVB 54.80
  • IE 45.79
  • Support Level
  • NUVB $3.20
  • IE $8.55
  • Resistance Level
  • NUVB $3.44
  • IE $9.24
  • Average True Range (ATR)
  • NUVB 0.26
  • IE 0.33
  • MACD
  • NUVB -0.02
  • IE 0.02
  • Stochastic Oscillator
  • NUVB 23.58
  • IE 59.86

About NUVB Nuvation Bio Inc.

Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. Its product candidate, taletrectinib, is an oral, potent, central nervous system-active, selective, next-generation c-ros oncogene 1 (ROS1) inhibitor specifically designed for the treatment of patients with ROS1+ non-small cell lung cancer (NSCLC). In addition, its clinical-stage pipeline includes differentiated, novel oncology product candidates such as Safusidenib, NUV-1511, and NUV-868 in their different stages of development. The company generates revenue through out-licensing collaborative agreements with its customers located in China and Japan.

About IE Ivanhoe Electric Inc.

Ivanhoe Electric Inc is a United States-based d minerals exploration company with a focus on developing mines from mineral deposits principally located in the United States. The company has four business segments; Santa Cruz Project; critical metals; data processing services; and energy storage. It derives a majority of its revenue from Canada. The Santa Cruz Project and critical metals segments are focused on mineral project exploration and development. The data processing segment provides data analytics, geophysical modeling, and artificial intelligence services for the mineral, oil & gas, and water exploration industries. The energy storage segment develops, manufactures, and installs vanadium flow batteries for grid-scale energy storage.

Share on Social Networks: